NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MRK

Merck & Co Inc

Apr 17 • 04:00PM ET

78.00

Dollar change +1.54
Percentage change 2.01	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO IVV SPY SCHD VTV XLV VIG VYM IWF

Scroll to Statements

Index	DJIA, S&P 500	P/E	11.58	EPS (ttm)	6.73	Insider Own	0.09%	Shs Outstand	2.53B	Perf Week	0.58%
Market Cap	196.28B	Forward P/E	7.93	EPS next Y	9.84	Insider Trans	0.04%	Shs Float	2.51B	Perf Month	-17.04%
Income	17.12B	PEG	0.93	EPS next Q	2.14	Inst Own	80.41%	Short Float	1.51%	Perf Quarter	-22.54%
Sales	63.97B	P/S	3.07	EPS this Y	16.93%	Inst Trans	1.39%	Short Ratio	2.16	Perf Half Y	-30.06%
Book/sh	18.32	P/B	4.26	EPS next Y	9.96%	ROA	15.30%	Short Interest	37.94M	Perf Year	-37.63%
Cash/sh	5.47	P/C	14.26	EPS next 5Y	12.47%	ROE	40.81%	52W Range	75.93 - 134.63	Perf YTD	-21.59%
Dividend Est.	3.29 (4.22%)	P/FCF	10.85	EPS past 5Y	12.04%	ROI	20.96%	52W High	-42.06%	Beta	0.50
Dividend TTM	3.16 (4.05%)	Quick Ratio	1.15	Sales past 5Y	7.14%	Gross Margin	74.68%	52W Low	2.73%	ATR (14)	2.99
Dividend Ex-Date	Mar 17, 2025	Current Ratio	1.36	EPS Y/Y TTM	4577.79%	Oper. Margin	33.37%	RSI (14)	33.43	Volatility	3.02% 3.66%
Employees	75000	Debt/Eq	0.83	Sales Y/Y TTM	6.85%	Profit Margin	26.76%	Recom	1.81	Target Price	112.72
Option/Short	Yes / Yes	LT Debt/Eq	0.76	EPS Q/Q	404.83%	Payout	46.32%	Rel Volume	1.21	Prev Close	76.46
Sales Surprise	0.91%	EPS Surprise	6.88%	Sales Q/Q	7.60%	Earnings	Apr 24 BMO	Avg Volume	17.55M	Price	78.00
SMA20	-7.16%	SMA50	-11.39%	SMA200	-24.74%	Trades		Volume	21,302,433	Change	2.01%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115
Mar-06-23	Initiated	Jefferies	Buy	$125
Feb-22-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$127

Show Previous Ratings

Today 01:13PM	Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now? (Insider Monkey)
01:06PM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings? (Zacks)
10:01AM	Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:55AM	Merck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
09:00AM	Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock (Zacks)
04:28PM	Loading…
Apr-16-25 04:28PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
01:05PM	Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now? (Zacks)
12:56PM	Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? (Insider Monkey)
09:53AM	Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now? (Insider Monkey)
Apr-15-25 10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
09:59AM	Merck & Co. Inc. (MRK): Among the High Growth Forever Dividend Stocks to Invest In (Insider Monkey)
09:09AM	The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now (Seeking Alpha)
07:35AM	Johnson & Johnson (JNJ) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:54AM	The Zacks Analyst Blog Merck and AbbVie (Zacks)
05:50PM	Loading…
Apr-14-25 05:50PM	Merck (MRK) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
10:37AM	ABBV vs. MRK: Which Drug Giant is a Better Buy Now? (Zacks)
10:29AM	Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds? (Insider Monkey)
09:08AM	Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition (Seeking Alpha)
05:57AM	Here's Why Summit Therapeutics Stock Soared 15% on Friday (Zacks)
Apr-13-25 05:57PM	Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires? (Insider Monkey)
02:12PM	DJD: Dividend And Value In Mega Caps (Seeking Alpha)
09:15AM	SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade) (Seeking Alpha)
Apr-11-25 12:33PM	Jim Cramer on Merck (MRK): Stay The Course… It's Been a Real Tough One (Insider Monkey)
11:15AM	OakmarkFund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 12:58PM	S&P, Dow Jones Pharma Names Rattled Again On Trump's Tariffs Whiplash (Investor's Business Daily) -5.32%
08:55AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
Apr-09-25 06:32PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
03:59PM	Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out (Seeking Alpha)
10:43AM	Apple, Alibaba, drugmaker stocks: Trending Tickers (Yahoo Finance Video)
10:11AM	Loading…
10:11AM	Trump says pharmaceutical tariffs may be coming: What to know (Yahoo Finance Video)
10:06AM	Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan (Investor's Business Daily)
09:57AM	Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance (Investor's Business Daily)
03:15AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
Apr-08-25 06:15PM	Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On (Insider Monkey)
10:03AM	Walgreens, CVS, & US drugmakers make big moves: What to know (Yahoo Finance Video)
Apr-07-25 01:46PM	Merck & Co., Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights MRK (GlobeNewswire)
08:37AM	Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes (Zacks)
05:10AM	2 Reasons to Like MRK (and 1 Not So Much) (StockStory)
Apr-05-25 08:14AM	Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout (Seeking Alpha)
08:00AM	5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (April 2025) (Seeking Alpha)
Apr-03-25 05:45PM	Merck (MRK) Stock Moves -0.24%: What You Should Know (Zacks) -5.70%
03:15PM	Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market (Seeking Alpha)
10:30AM	Pharma Stocks Aren't in the Clear, Despite Tariff ExemptionHeard on the Street (The Wall Street Journal)
09:27AM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
Apr-02-25 09:43AM	PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters (Zacks)
09:30AM	Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? (Zacks)
09:14AM	The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck (Zacks)
08:15AM	2 Beaten-Down Stocks to Buy and Hold for a Decade (Motley Fool)
Apr-01-25 08:38PM	My Top 10 High-Yield Dividend Stocks For April 2025 (Seeking Alpha)
07:09PM	Why Major Pharmaceutical Stocks Tumbled on Tuesday (Motley Fool)
04:59PM	Top Analyst Reports for Amazon, Oracle & Merck (Zacks)
02:02PM	The FDA Is Finished as Firings Sweep Health Agencies. Drug Stocks Are Falling. (Barrons.com)
12:05PM	Dogs Of The Dow Chase April's 'Safer' Buy (Seeking Alpha)
06:45AM	Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24 (Business Wire)
Mar-31-25 04:18PM	Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol? (Investor's Business Daily)
10:00AM	WINREVAIR (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial (Business Wire)
Mar-30-25 09:05AM	Putnam Large Cap Growth Fund Q4 2024 Commentary (Seeking Alpha)
05:00AM	Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors (Seeking Alpha)
Mar-29-25 01:55AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 30 (Seeking Alpha)
Mar-28-25 10:31PM	Why Merck & Co. Inc. (MRK) Went Up On Friday? (Insider Monkey)
05:45PM	Why the Market Dipped But Merck (MRK) Gained Today (Zacks)
04:00PM	China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market (Investor's Business Daily)
11:20AM	FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda (Zacks)
09:44AM	AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (Seeking Alpha)
08:30AM	Which Dow Jones Stock Is Cheaper, Amgen or Merck? (Motley Fool)
Mar-27-25 08:47PM	Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update (SeekingAlpha)
05:36PM	Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher? (InsiderMonkey)
04:20PM	Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares? (Investor's Business Daily)
04:14PM	Merck releases positive data for blockbuster cancer drug (Yahoo Finance Video)
11:34AM	Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive (Zacks)
11:01AM	Mercks Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial (Business Wire)
11:00AM	Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form (Yahoo Finance)
08:30AM	Is Merck Stock a Bargain Buy? (Motley Fool)
Mar-26-25 09:41PM	Here is Why Jim Cramer Is Bullish About Merck (MRK) (InsiderMonkey)
06:09PM	Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy? (InsiderMonkey)
05:50PM	Merck (MRK) Gains As Market Dips: What You Should Know (Zacks)
03:00PM	Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold? (Zacks)
01:45PM	Jim Cramer on Merck (MRK): "I Like It at This Level - But I Like Bristol-Myers Even More!" (InsiderMonkey)
12:31PM	5 Reasons To Buy Regenxbio Right Now (SeekingAlpha)
11:00AM	Forget S&P 500 And Buy These Dividend Icons Instead (SeekingAlpha)
09:28AM	Merck & Co.: Looming Patent Expiries For Key Drugs Weakens Longer-Term Outlook (SeekingAlpha)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:17AM	Merck Inks $2B Licensing Deal With Chinese Biotech for Oral Heart Drug (Zacks)
06:45AM	European Commission (EC) Approves Mercks CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults (Business Wire)
05:19AM	Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday? (InsiderMonkey)
Mar-25-25 06:47PM	Why Pharma and Biotech Stocks Got Thrashed on Tuesday (Motley Fool)
05:48PM	Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility? (InsiderMonkey)
03:00PM	Merck Bets $2B on China's Hengrui for Next Big Heart Drug (GuruFocus.com)
09:42AM	Merck Will Pay Up to $2 Billion for Chinese Heart Drug (Bloomberg)
08:03AM	Trump tariffs drive pharma manufacturing to US but risk inflation and disruption (Pharmaceutical Technology)
07:59AM	Merck bets $200M on a new type of heart pill (BioPharma Dive)
06:45AM	Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Business Wire)
Mar-24-25 09:10AM	Is Merck & Co. (MRK) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
Mar-22-25 04:35PM	Merck & Co. (MRK): Among Stocks Insiders Were Piling Into Recently (Insider Monkey)
04:04PM	2 Beaten-Down Stocks to Buy on the Dip (Motley Fool)
01:40AM	The Davenport Balanced Income Fund Q4 2024 Commentary (SeekingAlpha)
Mar-21-25 03:41PM	MDPL: No Reason To Pay Those Hefty Fees For Now (SeekingAlpha)
12:20PM	The Davenport Value & Income Fund Q4 2024 Commentary (SeekingAlpha)
09:30AM	3 of Goldman Sachs' best investing tips for currently volatile markets (Yahoo Finance)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM
THULIN INGE G	Director	Feb 06 '25	Buy	88.25	2,833	250,000	2,933	Feb 07 04:09 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Feb 06 '25	Sale	88.76	2,361	209,551	7,085	Feb 07 04:07 PM
BAKER DOUGLAS M JR	Director	Feb 05 '25	Buy	88.50	15,000	1,327,500	16,000	Feb 07 04:04 PM
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM
Guindo Chirfi	Chief Marketing Officer	Aug 05 '24	Option Exercise	115.20	36,901	4,250,995	57,782	Aug 06 12:20 PM
Smart Dalton	SVP Fin. - Global Controller	May 03 '24	Option Exercise	128.26	2,046	262,420	4,708	May 06 04:10 PM
Smart Dalton	SVP Fin. - Global Controller	May 04 '24	Option Exercise	127.51	612	78,036	4,730	May 06 04:10 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	May 04 '24	Option Exercise	127.51	27,126	3,458,836	163,720	May 06 04:08 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 04 '24	Option Exercise	127.51	887	113,101	24,058	May 06 04:06 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	May 04 '24	Option Exercise	127.51	912	116,289	24,271	May 06 04:01 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '24	Option Exercise	128.80	2,262	291,346	21,831	May 02 04:29 PM
Smart Dalton	SVP Fin. - Global Controller	May 02 '24	Option Exercise	128.80	381	49,073	3,048	May 02 04:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience